Table 4 Summary of action statements ACTOR, CONTEXT, TARGET and TIME criteria analysis by standard
| Â | Actions with behaviourally relevant content | ACTOR(s) was specified | CONTEXT was specified | TARGET(s) was specified | TIME was specified | ||||
|---|---|---|---|---|---|---|---|---|---|
Standard | No. | Meets criteria No. (%) | Meets criteria No. (%) | Partially meets criteria No. (%) | Meets criteria No. (%) | Partially meets criteria No. (%) | Not necessary No. (%) | Meets criteria No. (%) | Partially meets criteria No. (%) |
Standard 1: Fundamental Pharmacy Practice | 48 | 0 | 0 | 5 (10%) | 14 (29%) | 23 (48%) | 1 (2%) | 8 (17%) | 6 (13%) |
Standard 2: Leading and Managing Pharmacy Practice | 51 | 0 | 0 | 6 (12%) | 2 (4%) | 28 (55%) | 7 (14%) | 2 (4%) | 7 (14%) |
Standard 3: Dispensing and Other Supply Arrangements | 70 | 0 | 5 (7%) | 2 (3%) | 17 (24%) | 28 (40%) | 2 (3%) | 12 (17%) | 9 (13%) |
Standard 4: Provision of Non-prescription Medicines and Therapeutic Devices | 30 | 0 | 1 (3%) | 0 | 8 (27%) | 11 (37%) | 2 (7%) | 7 (23%) | 4 (13%) |
Standard 5: Compounding | 75 | 0 | 3 (4%) | 8 (11%) | 4 (5%) | 14 (19%) | 5 (7%) | 14 (19%) | 20 (27%) |
Standard 6: Medicines Information | 23 | 0 | 0 | 1 (4%) | 6 (26%) | 13 (57%) | 1 (4%) | 2 (9%) | 3 (13%) |
Standard 7: Health Promotion and Education | 21 | 0 | 1 (5%) | 0 | 1 (5%) | 14 (67%) | 1 (5%) | 2 (10%) | 1 (5%) |
Standard 8: Counselling | 36 | 0 | 2 (6%) | 0 | 11 (31%) | 10 (28%) | 0 | 3 (8%) | 3 (8%) |
Standard 9: Collaborative Care | 52 | 0 | 0 | 2 (4%) | 2 (4%) | 31(60%) | 2 (4%) | 1 (2%) | 4 (8%) |
Standard 10: Screening and Risk Assessment | 36 | 0 | 1 (3%) | 0 | 7 (19%) | 8 (22%) | 4 (11%) | 3 (8%) | 7 (19%) |
Standard 11: Vaccination Service | 65 | 0 | 0 | 4 (6%) | 12 (18%) | 29 (45%) | 2 (3%) | 8 (12%) | 12 (18%) |
Standard 12: Minor Ailments Service | 39 | 0 | 0 | 2 (5%) | 6 (15%) | 13 (33%) | 0 | 3 (8%) | 6 (15%) |
Standard 13: Disease State Management | 47 | 0 | 0 | 1 (2%) | 10 (21%) | 19 (40%) | 4 (9%) | 2 (4%) | 5 (11%) |
Standard 14: Medication Review | 52 | 0 | 1 (2%) | 3 (6%) | 11 (21%) | 25 (48%) | 0 | 4 (8%) | 7 (13%) |
Standard 15: Dose Administration Aid Service | 73 | 0 | 8 (11%) | 0 | 10 (14%) | 22 (30%) | 3 (4%) | 12 (16%) | 16 (22%) |
Standard 16: Harm Minimisation | 50 | 0 | 3 (6%) | 1 (2%) | 10 (20%) | 15 (30%) | 2 (4%) | 6 (12%) | 9 (18%) |
Total | 768 | 0 | 25 (3%) | 35 (5%) | 131(17%) | 303 (39%) | 36 (5%) | 88 (11%) | 120 (16%) |